Status: Recruiting
A Clinical Study Evaluating the Safety and Efficacy of SKG0106 in Patients With Neovascular Age-related Macular Degeneration (nAMD)
This is a clinical study to evaluate the safety, preliminary efficacy, immunogenicity of SKG0106 in subjects with nAMD.
Participants needed: 12
Trial details
Phase: Phase 1Age: 50+Biological sex: AllType: InterventionalSponsor: Youxin ChenUpdated: Jan 8, 2025Locations: 3
Eligibility criteria
Voluntary and able to sign a dated ICF prior to any study-related procedures and... [+4]
Any active intraocular or periocular infection or active intraocular inflammatio... [+5]